NASDAQ: GDTC
Cytomed Therapeutics Ltd Stock Ownership - Who owns Cytomed Therapeutics?

Insider buying vs selling

Have Cytomed Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chee Kong ChooDirector2026-07-20100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-20100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-14100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-07-14100,000$1.50
$150.00kBuy
Chee Kong ChooDirector2026-05-13112,000$1.15
$128.80kBuy

1 of 1

GDTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GDTC insiders and whales buy or sell their stock.

GDTC Shareholders

What type of owners hold Cytomed Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Glorious Finance Ltd39.34%4,653,604$4.60MInsider
Chee Kong Choo27.99%3,310,261$3.27MInsider
Shu Wang7.47%883,858$874.14kInsider
Jieming Zeng4.98%589,239$582.76kInsider
Lucas Tien Wee Luk0.78%92,563$91.54kInsider
Yvonne Goh0.22%25,781$25.50kInsider
Yoong Ying Tan0.22%25,781$25.50kInsider
Xtx Topco Ltd0.09%10,136$10.02kInstitution
Ubs Group Ag0.05%6,182$6.11kInstitution
Keng Kiat Toh0.03%4,000$3.96kInsider

1 of 2

GDTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GDTC0.14%81.06%Net BuyingNet Buying
INTS5.26%4.73%Net BuyingNet Buying
COCP0.88%99.12%Net Buying
KPRX2.70%97.30%Net SellingNet Selling
SNTI18.06%81.94%

Cytomed Therapeutics Stock Ownership FAQ

Who owns Cytomed Therapeutics?

Cytomed Therapeutics (NASDAQ: GDTC) is owned by 0.14% institutional shareholders, 81.06% Cytomed Therapeutics insiders, and 18.81% retail investors. Glorious Finance Ltd is the largest individual Cytomed Therapeutics shareholder, owning 4.65M shares representing 39.34% of the company. Glorious Finance Ltd's Cytomed Therapeutics shares are currently valued at $4.33M.

If you're new to stock investing, here's how to buy Cytomed Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.